RxAll logo

RxAll

Operating

RxAll is a multiple-award winning deep learning-hyperspectral IoT platform for authenticating drugs in real time.

Updated Source: SLA Startup IndexHow we verify →
Total raised
$6.8M
disclosed
Last round
$225K
Grant
Rounds
10
since 2016
Investors
16
on record
Employees
11-50

About RxAll

RxAll™ is an on-demand platform for safe drugs. We enable B2B2C deliveries of high quality medicines at manufacturer/wholesale price to hospitals, pharmacies and patients from our curated network of high quality wholesalers and pharma companies. We solve $200B problem of access to safe drugs. Our tech stack includes a proprietary instant drug testing platform- RxScanner™- that helps our sellers authenticate the medicines they sell. We also have the RxPOS™ that helps our sellers manage and sell inventory in store and online. Further, we have an extensive RxLogistics™ fleet of bikes and vans that enables supplies from our pharma company and wholesaler partners to our B2B2C customers. Our vision is to enable universal access to high quality medicines at the lowest prices to all humans across the world.

RxAll funding10 rounds

All 10 rounds →

RxAll has raised $6.8M across 10 disclosed rounds. The latest is a $225K Grant announced 30 Apr 2025, led by Investing In Innovation Africa.

Capital growthrunning total of disclosed rounds
  1. $60KGrantGrant, $60K, $60K raised to date
  2. $500KPre-seedPre-seed, $500K, $560K raised to date
  3. $112KGrantGrant, $112K, $672K raised to date
  4. $745KPre-seedPre-seed, $745K, $1.4M raised to date
  5. $2MSeedSeed, $2M, $3.4M raised to date
  6. $40KSeedSeed, $40K, $3.5M raised to date
  7. $3.1MFunding RoundFunding Round, $3.1M, $6.6M raised to date
  8. $225KGrantGrant, $225K, $6.8M raised to date

SLA Funding Index · grey is capital raised before each round · 2 undisclosed rounds not drawn

AnnouncedRoundLead · investorsAmount
30 Apr 2025RxAll GrantInvesting In Innovation Africa$225K
20 Jul 2021RxAll Funding RoundHAX +2$3.1M
01 Jan 2021RxAll Funding RoundLoftyInc Capital ManagementNot disclosed
10 Nov 2020RxAll Convertible NoteSOSV +1Not disclosed
21 Sep 2020RxAll SeedFounders Factory Africa$40K
17 Feb 2020RxAll SeedTakuma Terakubo +3$2M
30 Sep 2019RxAll Pre-seedHAX +1$745K
27 Mar 2019RxAll GrantBNP Paribas$112K
01 Jun 2018RxAll Pre-seedKatapult Accelerator$500K
31 Aug 2017RxAll GrantYale University +2$60K

RxAll founders & team

RxAll competitorssame sector · similar funding

  • Whispa Health

    WHISPA is a mobile application that provides young people with private access to Sexual and Reproductive Health (SRH) information, products, and services. · Nigeria

  • Vittas

    Vittas is a health‑focused fintech startup providing credit infrastructure for businesses in Africa’s healthcare ecosystem. · Nigeria

  • Elera

    Eléra is building an infrastructure where healthcare providers, payment partners, and patients connect and communicate in one App. · Nigeria

  • Bridges Diagnostics Limited

    Bridging the gap between quality healthcare services and the local/global community. · Nigeria

  • Lifestores

    Lifestores Healthcare is democratizing access to essential primary healthcare by transforming pharmacies and chemists · Nigeria

  • LifeBank

    LifeBank is a platform that makes blood available when and where it is needed in Nigeria to save lives. · Nigeria

All 11 HealthCare startups in Nigeria

Frequently asked about RxAll

Where is RxAll based and when was it founded?
RxAll is headquartered in Lagos, Nigeria and was founded in 2016.
Who founded RxAll?
RxAll was founded by Adebayo Alonge (Co-Founder & CEO).
Who is the CEO of RxAll?
Adebayo Alonge is RxAll's Co-Founder & CEO.
How much funding has RxAll raised?
RxAll has raised $6.8M across 10 disclosed rounds. Its latest, a $225K Grant, was announced on Apr 30, 2025.
Who has invested in RxAll?
Backers include Investing In Innovation Africa, HAX, Launch Africa, KSK fund and 12 others.
What sector is RxAll in?
RxAll operates in HealthCare, Artificial Intelligence and IoT.